<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132758">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01842178</url>
  </required_header>
  <id_info>
    <org_study_id>CIRH-OLE:2013</org_study_id>
    <nct_id>NCT01842178</nct_id>
  </id_info>
  <brief_title>Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation</brief_title>
  <official_title>Randomized Prospective Study of Endometrial Injury in In Vitro Fertilization Cycles With Oocyte Donation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Infertilidad y Reproducción Humana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Infertilidad y Reproducción Humana</source>
  <oversight_info>
    <authority>Spain: Comité Ético de Investigación Clínica</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the potential benefit in pregnancy rates produced by an
      endometrial scratching made in an IVF cycle prior to embryo transfer in patients with
      donated oocytes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, comparative, prospective, double Blind study.

      The First stage of this study consists of revising the patients medical records to identify
      possible candidates. Patients indicated are randomized into two groups: experimental and
      control. They are followed up to 12 week of pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>biochemical pregnancy</measure>
    <time_frame>14-16 days post-follicular  punction</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Determination of human chorionic gonadotropin blood levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>6 pregnancy weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Ultrasound</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Evolutionary pregnancy</measure>
    <time_frame>12 weeks of pregnancy</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>telephone patient contact</description>
  </other_outcome>
  <other_outcome>
    <measure>abortion</measure>
    <time_frame>6-12 week of pregnancy</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>telephone contact of patients</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Subfertility</condition>
  <arm_group>
    <arm_group_label>scratching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will have an endometrial injury done on purpose, between 18-24 days prior to IVF cycle with a transfer catheter on the surgery outpatient department.
Endometrial Injury
Done between 18-24 days prior to embryo transfer cycle.
Using transfer catheter.
Introduction of the same to the uterine fundus.
Systematic scrapping of the four uterine walls, lengthwise.
Performed by a skilled doctor.
Subsequent ultrasound control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scratching simulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will come to control visit between day 18-24. A scratching simulation will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scratching</intervention_name>
    <description>Endometrial Injury
Done between 18-24 days prior to embryo transfer cycle.
Using transfer catheter.
Introduction of the same to the uterine fundus.
Systematic scrapping of the four uterine walls, lengthwise.
Performed by a skilled doctor.
Subsequent ultrasound control.</description>
    <arm_group_label>scratching</arm_group_label>
    <other_name>endometrial enjury</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Do IVF cycle with donor eggs

          -  Will adjust to protocol for the study.

          -  Have signed informed consent

        Exclusion Criteria:

          -  Clinically significant systemic disease, hypothalamic or pituitary tumors

          -  ovarian, uterine or breast cancer

          -  hormonal abnormalities and / or medical , biochemistry, hematology pathology, which
             might interfere with gonadotropin treatment.

          -  known positivity for human immunodeficiency virus (HIV), hepatitis C or B virus (HCV
             / HBV) of the candidate or her partner.

          -  Uterine Factor(submucosal fibroids, intramural fibroids&gt; 4 cm)

          -  Hydrosalpinx

          -  Patients receiving immune treatment

          -  Positive Diagnosis Thrombophilia

          -  preimplantation genetic diagnosis needed

          -  In case of using marital sperm are excluded the following patients:Altered male
             karyotype, Altered Meiosis in testicular biopsy, Altered FISH, sperm Fragmentation&gt;
             45%

          -  Pregnancy contraindication

          -  Known allergy to preparations containing estrogens or any of its excipients.

          -  Simultaneous participation in another clinical trial with medication.

          -  Do not want or can not adjust to study protocol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>miguel angel checa</last_name>
    <role>Study Director</role>
    <affiliation>CIRH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ana perez alzueta</last_name>
    <phone>671679740</phone>
    <email>aperez@cirh.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro de Infertilidad y Reproducción Humana</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ana perez alzueta, doctor</last_name>
      <phone>671679740</phone>
      <email>aperezalz@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>mario brassesco</last_name>
      <phone>932806535</phone>
    </contact_backup>
    <investigator>
      <last_name>ana perez alzueta, gynecologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 26, 2013</lastchanged_date>
  <firstreceived_date>April 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
